News and Events

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

24 January 2020

Results of this recent study indicate that tertiary lymphoid structures have a key role in the immune microenvironment in melanoma, by conferring distinct T cell phenotypes. Therapeutic strategies to induce the formation of tertiary lymphoid structures should be explored to improve responses to cancer immunotherapy.

Refreshed #DumbBurn Skin Cancer Prevention Campaign

23 January 2020

The Health Promotion Agency has refreshed their skin cancer prevention campaign, '#Dumbburn', which encourages young people to avoid getting sunburnt. It will run through until the end of February 2020. 

Dabrafenib demonstrates durable outcomes in some patients with BRAF-mutant melanoma

11 January 2020

According to this recent study, the use of dabrafenib monotherapy for treatment-naive or previously treated BRAF V600E/K-mutant metastatic melanoma can result in durable outcomes of five years or more in a subset of patients. The study also demonstrates progression-free and overall survival with dabrafenib may plateau after 36 months and long-term treatment with dabrafenib monotherapy is well tolerated.